Manuscripts and Publications
Filters: Author is Cho, Michael H [Clear All Filters]
Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes.. PLoS Genet. 19(6):e1010445.
.
2023. Large scale proteomic studies create novel privacy considerations. Sci Rep. 13(1):9254.
.
2023. .
2023. A Metabolomic Severity Score for Airflow Obstruction and Emphysema.. Metabolites. 12(5)
.
2022. Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle. 12(6):1803-1817.
.
2021. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.. Respir Res. 22(1):127.
.
2021. Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.. Lancet Respir Med. 8(7):696-708.
.
2020. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 201(5):564-574.
.
2020. Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules.. Netw Syst Med. 3(1):159-181.
.
2020. A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study.. Chronic Obstr Pulm Dis. 7(4):346-361.
.
2020. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations.. Nat Genet. 51(3):494-505.
.
2019. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat Genet. 51(3):481-493.
.
2019. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 200(11):1402-1413.
.
2019. .
2018.
.
2017.
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.. PLoS Genet. 12(8):e1006011.
.
2016.